TY  - JOUR
AU  - Manterola, Andrea
AU  - Bernal Chico, Ana
AU  - Cipriani, Raffaela
AU  - Canedo Antelo, Manuel
AU  - Moreno García, Álvaro
AU  - Martín Fontecha, Mar
AU  - Pérez Cerdá, Fernando
AU  - Sánchez Gómez, María Victoria
AU  - Ortega Gutiérrez, Silvia
AU  - Brown, J. Mark
AU  - Hsu, Ku-Lung
AU  - Cravatt, Benjamin
AU  - Matute, Carlos
AU  - Mato, Susana
PY  - 2018
DO  - 10.1016/j.bcp.2018.07.042
SN  - 0006-2952
UR  - https://hdl.handle.net/20.500.14352/13002
T2  - Biochemical Pharmacology
AB  - Multiple sclerosis (MS) is a chronic demyelinating disease of unknown etiology in which tissue pathology suggests both immune-dependent attacks to oligodendroglia and primary oligodendrocyte demise. The endocannabinoid system has been crucially...
LA  - eng
M2  - 189
PB  - Elsevier
KW  - Cuprizone
KW  - Demyelination
KW  - ABHD6
KW  - Cannabinoid receptors
KW  - Oligodendrocyte
KW  - Microglia
TI  - Deregulation of the endocannabinoid system and therapeutic potential of ABHD6 blockade in the cuprizone model of demyelination
TY  - journal article
VL  - 157
ER  -